Exova Group PLC Publication of Prospectus (6566E)
April 11 2014 - 6:27AM
UK Regulatory
TIDMEXO
RNS Number : 6566E
Exova Group PLC
11 April 2014
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN
PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES,
AUSTRALIA, CANADA, JAPAN, OR ANY OTHER JURISDICTION WHERE TO DO SO
MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF
SUCH JURISDICTION.
FOR IMMEDIATE RELEASE
11 April 2014
Exova Group plc
Publication of Prospectus
Exova Group plc ("Exova" or the "Company") has today published a
prospectus (the "Prospectus") in connection with the admission of
the Company's ordinary shares ("Shares") to trading on the main
market for listed securities of the London Stock Exchange plc
("London Stock Exchange").
The Prospectus has been approved by the UK Listing Authority.
Copies of the Prospectus are available free of charge during normal
business hours from the registered office of the Company at 6
Coronet Way Centenary Park Eccles, Manchester M50 1RE and will
shortly be made available on the website of the Company
(www.exova.com/ipo).
The Prospectus has also been submitted to the National Storage
Mechanism and will shortly be available at
www.morningstar.co.uk/uk.
Enquiries
Exova Group plc +44 (0) 207 240 2486
Ian El-Mokadem, Chief Executive Officer
Anne Thorburn, Chief Financial Officer
Joint Global Co-ordinators, Joint Sponsors and Joint
Bookrunners
Credit Suisse +44 (0) 207 888 8888
Jon Grussing
Jens Haas
Nick Koemtzopoulos
Michael Taylor
Goldman Sachs International +44 (0) 207 774 1000
Richard Cormack
Anthony Gutman
Alex Garner
Duncan Stewart
Joint Bookrunner
Barclays +44 (0) 207 623 2323
Richard Probert
Mark Astaire
Alex de Souza
Ben West
Financial Adviser to Exova
Rothschild +44 (0) 207 280 5000
Adam Young
Alistair Allen
Public Relations
StockWell Communications +44 (0) 207 240 2486
Anthony Silverman
Zoƫ Watt
Disclaimer
This announcement is an advertisement for the purposes of the UK
Prospectus Rules of the Financial Conduct Authority (the "FCA") and
not a prospectus. Investors should not purchase or subscribe for
any shares referred to in this announcement except on the basis of
information in the Prospectus published by Exova in connection with
the admission of its Shares to the premium listing segment of the
Official List of the FCA and to trading on the main market for
listed securities of London Stock Exchange. A copy of the
Prospectus will be available on the Company's website at
www.exova.com/ipo.
This announcement is not an offer to sell, or a solicitation of
an offer to acquire, securities in the United States or in any
other jurisdiction, including in or into Australia, Canada, Japan
or the United States. References in this announcement to "Exova" or
the "Group" mean the Company, together with its consolidated
subsidiaries and subsidiary undertakings following a pre-IPO
reorganisation.
Neither this announcement nor the information contained herein
is for publication or distribution, in whole or in part, directly
or indirectly, in or into Australia, Canada, Japan, the United
States (including its territories and possessions, any State of the
United States and the District of Columbia) or any other
jurisdiction where to do so would constitute a violation of the
relevant laws of such jurisdiction. The Offer or distribution of
this announcement and other information in connection with
Admission and the Offer may be restricted by law in certain
jurisdictions and persons into whose possession any document or
other information referred to herein comes should inform themselves
about and observe any such restriction. Any failure to comply with
these restrictions may constitute a violation of the securities
laws of any such jurisdiction.
The securities referred to herein may not be offered or sold,
directly or indirectly, in the United States unless registered
under the U.S. Securities Act of 1933, as amended (the "U.S.
Securities Act") or offered in a transaction exempt from, or not
subject to, the registration requirements of the U.S. Securities
Act. The offer and sale of securities referred to herein has not
been and will not be registered under the U.S. Securities Act or
under the applicable securities laws of Australia, Canada or Japan.
There will be no public offer of the Shares in Australia, Canada,
Japan or the United States. Subject to certain exceptions, the
Shares referred to herein may not be offered or sold in Australia,
Canada or Japan or to, or for the account or benefit of, any
national, resident or citizen of Australia, Canada or Japan.
This information is provided by RNS
The company news service from the London Stock Exchange
END
PDIIBMBTMBTBBFI
Exova (LSE:EXO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Exova (LSE:EXO)
Historical Stock Chart
From Jul 2023 to Jul 2024